Table of contents

September 2005 Volume 2 No 9

Top

Editorial

Atherothrombosis as a systemic, often silent, disease

Valentin Fuster and Pedro R Moreno

431

doi:10.1038/ncpcardio0310 | Full Text | PDF (48K)

Top

Viewpoint

Childhood obesity and cardiovascular disease: the challenge ahead

Peter H Whincup and John E Deanfield

432

doi:10.1038/ncpcardio0295 | Full Text | PDF (67K)

Top

Research Highlights

Assessment of coronary lesions with 64-slice CT

Ruth Kirby

434

doi:10.1038/ncpcardio0264 | Full Text | PDF (63K)

Identifying surgical candidates among prosthetic-valve endocarditis patients

Pippa Murdie

434

doi:10.1038/ncpcardio0266 | Full Text | PDF (63K)

Calcium concentration of individual plaques: a new marker of coronary calcification?

Claire Braybrook

434

doi:10.1038/ncpcardio0279 | Full Text | PDF (70K)

Novel drug-eluting stent system prevents restenosis

Pippa Murdie

435

doi:10.1038/ncpcardio0280 | Full Text | PDF (63K)

Endovascular versus open repair for abdominal aortic aneurysm: EVAR trial 1

Claire Braybrook

435

doi:10.1038/ncpcardio0281 | Full Text | PDF (69K)

After ischemic stroke, patients are at higher risk of recurrent stroke than of cardiac events

Christine Kyme

436

doi:10.1038/ncpcardio0283 | Full Text | PDF (60K)

Does coating stents with titanium oxynitride reduce restenosis?

Rebecca Ireland

436

doi:10.1038/ncpcardio0285 | Full Text | PDF (67K)

Management of abdominal aortic aneurysm in patients unfit for open repair surgery: EVAR trial 2

Claire Braybrook

436

doi:10.1038/ncpcardio0288 | Full Text | PDF (60K)

Pulmonary-vein isolation with radiofrequency ablation as first-line therapy for atrial fibrillation

Rachael Williams

437

doi:10.1038/ncpcardio0284 | Full Text | PDF (61K)

Elevated levels of tumor markers in heart failure patients

Claire Braybrook

437

doi:10.1038/ncpcardio0286 | Full Text | PDF (68K)

Pioglitazone improves cardiovascular risk markers for patients with diabetes

Caroline Barranco

438

doi:10.1038/ncpcardio0282 | Full Text | PDF (61K)

Valsartan reduces atrial fibrillation in patients with heart failure

Rebecca Ireland

438

doi:10.1038/ncpcardio0287 | Full Text | PDF (61K)

Caution against using cyclo-oxygenase 2 inhibitors for pain after cardiac surgery

Rachael Williams

439

doi:10.1038/ncpcardio0289 | Full Text | PDF (63K)

Cost-effectiveness of sirolimus-eluting stents compared with bare-metal stents

Caroline Barranco

439

doi:10.1038/ncpcardio0290 | Full Text | PDF (63K)

Top

Practice Points

Is eplerenone a cost-effective therapy for heart failure patients after myocardial infarction?

Kenneth Dickstein

440

doi:10.1038/ncpcardio0296 | Full Text | PDF (73K)

Cardiac dimensions and function in atrial fibrillation: how do rate and rhythm control compare?

Zayd A Eldadah and S Adam Strickberger

442

doi:10.1038/ncpcardio0294 | Full Text | PDF (73K)

Is clopidogrel plus aspirin more cost-effective than aspirin alone in high-risk patients with acute coronary syndromes?

Keith AA Fox

444

doi:10.1038/ncpcardio0297 | Full Text | PDF (73K)

Pulmonary-vein cryoisolation versus left-atrial linear cryoablation for atrial fibrillation

Kalyanam Shivkumar

446

doi:10.1038/ncpcardio0308 | Full Text | PDF (65K)

Does angiotensin-converting-enzyme inhibitor therapy improve cognitive function in heart failure patients?

Michael Böhm and Ingrid Kindermann

448

doi:10.1038/ncpcardio0292 | Full Text | PDF (71K)

Top

Reviews

Large-artery stiffness, hypertension and cardiovascular risk in older patients

Jacques Blacher and Michel E Safar

450

doi:10.1038/ncpcardio0307 | Full Text | PDF (144K)

The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications

CJ Slager, JJ Wentzel, FJH Gijsen, A Thury, AC van der Wal, JA Schaar and PW Serruys

456

doi:10.1038/ncpcardio0298 | Full Text | PDF (576K)

Drug Insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options

Martin T Rothman

465

doi:10.1038/ncpcardio0311 | Full Text | PDF (161K)

Mechanisms of Disease: beta-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failure

David S Feldman, Cynthia A Carnes, William T Abraham and Michael R Bristow

475

doi:10.1038/ncpcardio0309 | Full Text | PDF (177K)

Top

Case Study

Continuing Medical Education

Vasospastic angina pectoris associated with Churg–Strauss syndrome

Paraskevi Petrakopoulou, Wolfgang M Franz, Peter Boekstegers and Michael Weis

484

doi:10.1038/ncpcardio0299 | Full Text | PDF (351K)

Extra navigation

.

ADVERTISEMENT